We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAP
4951
DELISTED
Adaptimmune Therapeutics
ADAP
$2.56M ﹤0.01%
1,506,155
-242,336
-14% -$416K
VFQY icon
4952
Vanguard US Quality Factor ETF
VFQY
$506M
$2.56M ﹤0.01%
+26,106
New +$2.79M
GDRX icon
4953
CALL
GoodRx Holdings
GDRX
$1.27B
$2.56M ﹤0.01%
431,600
-26,400
-6% -$294K
NRP icon
4954
CALL
Natural Resource Partners
NRP
$1.39B
$2.55M ﹤0.01%
68,600
-1,700
-2% -$77.1K
AJRD
4955
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$2.55M ﹤0.01%
62,900
-41,900
-40% -$1.69M
SKT icon
4956
PUT
Tanger
SKT
$4.42B
$2.55M ﹤0.01%
179,500
-23,100
-11% -$383K
ABNB icon
4957
Airbnb
ABNB
$110B
$2.55M ﹤0.01%
28,630
-916,109
-97% -$119M
VUG icon
4958
Vanguard Morningstar Growth ETF
VUG
$230B
$2.55M ﹤0.01%
68,628
-106,092
-61% -$4.36M
TECS icon
4959
CALL
Direxion Daily Technology Bear 3x ETF
TECS
$59.6M
$2.54M ﹤0.01%
509
+23
+5% +$98.9K
ISEE
4960
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.54M ﹤0.01%
264,600
+158,200
+149% +$1.99M
VRP icon
4961
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$2.54M ﹤0.01%
114,640
+6,161
+6% +$143K
CPER icon
4962
CALL
United States Copper Index Fund
CPER
$774M
$2.54M ﹤0.01%
114,400
+38,000
+50% +$997K
WEAT icon
4963
PUT
Teucrium Wheat Fund
WEAT
$303M
$2.54M ﹤0.01%
56,220
-7,980
-12% -$431K
SPWH icon
4964
Sportsman's Warehouse
SPWH
$46.4M
$2.54M ﹤0.01%
264,756
-250,136
-49% -$2.47M
AMSF icon
4965
AMERISAFE
AMSF
$513M
$2.54M ﹤0.01%
48,795
+30,453
+166% +$1.48M
BPT
4966
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$2.54M ﹤0.01%
124,000
-7,700
-6% -$138K
GBX icon
4967
The Greenbrier Companies
GBX
$1.41B
$2.54M ﹤0.01%
70,517
+33,318
+90% +$1.39M
LESL icon
4968
CALL
Leslie's
LESL
$6.04M
$2.54M ﹤0.01%
8,360
+2,910
+53% +$1.09M
RETA
4969
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.54M ﹤0.01%
83,500
-128,400
-61% -$3.83M
AB icon
4970
PUT
AllianceBernstein
AB
$3.41B
$2.54M ﹤0.01%
61,000
-27,400
-31% -$1.15M
COO icon
4971
PUT
Cooper Companies
COO
$14.9B
$2.54M ﹤0.01%
32,400
-76,800
-70% -$6.8M
PTEN icon
4972
CALL
Patterson-UTI
PTEN
$4.34B
$2.54M ﹤0.01%
160,900
+99,400
+162% +$1.67M
XTJL icon
4973
Innovator US Equity Accelerated Plus ETF July
XTJL
$16.9M
$2.54M ﹤0.01%
113,478
+12,300
+12% +$305K
STAA icon
4974
PUT
STAAR Surgical
STAA
$1.31B
$2.53M ﹤0.01%
35,700
-3,400
-9% -$219K
TOL icon
4975
Toll Brothers
TOL
$13.9B
$2.53M ﹤0.01%
56,787
-9,765
-15% -$457K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.